Inhibition of FAO by overexpressing HES1 alleviated SIRT3-induced chemoresistance in AML, suggesting that HES1 may be one of the key tumor suppressors outside the mitochondria targeted by SIRT3. This evidence concerns the gene HES1 and neoplasm.